SELLAS Life Sciences Group, Inc. (SLS)

SLS at 11.54 shows a neutral profile as short-term indicators hover near equilibrium while longer-term averages remain supportive. Momentum readings are mixed—RSI near 49 and MACD close to zero—while the ten- and twenty-period averages sit around the current price and the 200-day average is well below, indicating longer-term support. ADX is low, suggesting a lack of trend conviction, and OBV is positive, which favors buyers despite modest volatility indicated by ATR. The classic pivot sits near 11.61 so price is trading around balance. Technical takeaway: Neutral — indicators show balance between modest support and limited trend strength.